When following a renal (kidney disease) diet, consuming foods low in sodium, phosphorus, potassium, and protein is crucial to ...

The Food and Drug Administration (FDA) has added a new boxed warning on the denosumab drug label (brand name: Prolia) to alert clinicians to an increased risk for severe hypocalcemia in patients with ...

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with ...

Ketoanalogue supplements can enable patients to continue to meet their protein needs without exacerbating nitrogen load.

A new study published in the International Journal of General Medicine found that a severe vitamin D deficit (<10 ng/mL) ...

Denosumab treatment for osteoporosis appears more hazardous in postmenopausal women with advanced chronic kidney disease (CKD).

A recent study from the University of Hong Kong has found that sodium-glucose cotransporter 2 inhibitors (SGLT2i), a new type ...